| Patient | Natsume Sōseki |
|---|---|
| Date of birth | 1867-02-09 |
| Identifiers | MRN HR-ET023-SYN-TD; SSN (made up) 000-23-8840 |
| Document date | 1910-06-04 |
| Author | Haruka Lindqvist-Mori, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week review: biopsy results, resistance testing, and eradication therapy. [S]
Mr. Natsume returns two weeks after his endoscopy. The epigastric pain stopped within four days of starting vonoprazan, and he now sleeps through the night. His stools are dark and formed on iron, with no sticky, tarry stools; he has not vomited or felt faint. He takes the iron every other morning without stomach upset. He has taken no NSAIDs. He is writing his serial again each morning and eats at more regular hours. [S]
| Element | Detail |
|---|---|
| Pain | Gone within four days of vonoprazan |
| Stools | Dark and formed on iron; no tarry stools |
| Medicines | Vonoprazan 20 mg each morning; ferrous sulfate every other morning; no NSAIDs |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy a little better; no fever |
| Gastrointestinal | Negative | No epigastric pain, vomiting, or tarry stools; dark formed stools on iron |
| Cardiovascular | Negative | No lightheadedness |
| Integumentary | Negative | No rash |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for headache or pain, no more than 3 g a day (in place of ibuprofen) | One or two tablets every six hours as needed; no more than six tablets a day | Oral route | 1910-05-18 | active | S |
| Vonoprazan 20 mg oral tablet, one tablet by mouth each morning for eight weeks for gastric ulcer healing | One tablet each morning for eight weeks | Oral route | 1910-05-21 to 1910-07-16 | completed | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning | Oral route | 1910-05-21 | active | S |
| Vonoprazan 20 mg oral tablet, one extra tablet by mouth each evening for 14 days during eradication therapy (20 mg twice daily with the morning dose) | One tablet each evening for 14 days | Oral route | 1910-06-04 to 1910-06-17 | completed | S |
| Amoxicillin 500 mg oral capsule, two capsules (1 g) by mouth three times daily for 14 days | Two capsules three times daily for 14 days | Oral route | 1910-06-04 to 1910-06-17 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1910-06-04 | Body height | 159 | cm | S |
| 1910-06-04 | Body weight | 52.2 | kg | S |
| 1910-06-04 | Body mass index (BMI) [Ratio] | 20.6 | kg/m2 | S |
| 1910-06-04 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1910-06-04 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1910-06-04 | Heart rate | 78 | /min | S |
| 1910-06-04 | Respiratory rate | 14 | /min | S |
| 1910-06-04 | Body temperature | 36.6 | Cel | S |
| 1910-06-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1910-06-04 | Hemoglobin [Mass/volume] in Blood | 11.8 | g/dL | 13.2-17.1 g/dL | Low | S |
Vital signs recorded on 1910-06-04; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 52.2 kg; pulse 78, blood pressure 120/76 |
| Abdomen | Soft and non-tender |
| Conjunctivae | Slightly pale |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three weeks of gnawing epigastric pain, worse before meals and at night and eased by food, with two episodes of black, tarry stools ten days ago and iron-deficiency anemia; stable, Glasgow-Blatchford score 4; peptic ulcer suspected and urgent endoscopy booked | resolved | confirmed | R10.13 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its timing echoes his documented stomach illness of May 1910 (D). |
| Gastric ulcer, 15 mm, on the lesser curvature at the angulus, with recent bleeding (melena) and a clean base at endoscopy (Forrest III); margin biopsies benign; Helicobacter pylori positive; synthetic modern diagnosis for his documented gastric ulcer | active | confirmed | K25.4 | S — Synthetic modern diagnosis anchored to his documented gastric ulcer (D); the Helicobacter pylori cause is synthetic. |
| Helicobacter pylori infection (rapid urease test and histology positive; clarithromycin resistance mutation on biopsy PCR) | active | confirmed | B96.81 | S — Synthetic finding at endoscopy; no historical claim is made about the organism in his illness. |
| Iron-deficiency anemia from chronic blood loss (hemoglobin 11.2 g/dL, MCV 76 fL, ferritin 8 ng/mL) | active | confirmed | D50.0 | S — Synthetic finding at intake. |
| Chronic atrophic gastritis from Helicobacter pylori, moderate atrophy with focal intestinal metaplasia in the antrum (OLGA stage II, OLIM stage I; open-type endoscopic atrophy); no dysplasia; yearly endoscopic surveillance | active | confirmed | K29.40 | S — Synthetic histology finding at the two-week visit; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Upper endoscopy with biopsy of the ulcer margin | At diagnosis; repeat for a gastric ulcer at 8 to 12 weeks to confirm healing and biopsy the scar | Completed today | Margin biopsies benign; no dysplasia or cancer; repeat endoscopy at about ten weeks |
| Laboratory | Helicobacter pylori test (rapid urease test and histology) with clarithromycin-resistance testing | At diagnosis | Completed today | Histology positive; clarithromycin-resistance mutation on PCR |
| Medication safety | Eradication therapy: adherence and side effects | At the start and during the course | Completed today | Vonoprazan-amoxicillin dual therapy for 14 days started today; adherence and side effects explained |
| Laboratory | Test of eradication (13C urea breath test) | At least four weeks after antibiotics and two weeks after acid suppression | Due | About seven weeks after the course ends |
| Medication safety | Acid suppression for ulcer healing (vonoprazan) | Daily for eight weeks for a gastric ulcer | Completed today | Taking vonoprazan each morning; pain gone |
| Medication safety | NSAID avoidance | Every visit | Completed today | None taken |
| Self-management | Bleeding warning signs and when to call 119 | Every visit | Completed today | No tarry stools or vomiting; dark stools on iron explained |
| Self-management | Alcohol, smoking and meals | Every visit | Completed today | Meals more regular; no smoking; less salt advised |
| Laboratory | Blood count on oral iron | About four weeks after starting oral iron, then every three months for a year (CMID) | Completed today | Hemoglobin 11.8 g/dL two weeks after starting iron, up 0.8 g/dL; next at about four weeks |
| Laboratory | Gastric cancer surveillance: atrophy and intestinal metaplasia staging | At diagnosis, then endoscopy yearly after eradication when atrophy or intestinal metaplasia is present | Completed today | OLGA stage II, OLIM stage I; open-type atrophy; no dysplasia: yearly surveillance |
Goal progress:
Guideline basis: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection (2024); Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022); Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition (2016 (published 2019)); Evidence-based clinical practice guidelines for peptic ulcer disease 2026 (2026); ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding (2021); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026)
Follow-up: Blood count in about four weeks. Eleven-week review in early August with the urea breath test, repeat endoscopy, blood count and ferritin. Call 119 for black, tarry stools, vomiting blood or fainting. Next scheduled visit 1910-06-16: periodic adult preventive visit. [S]